333 related articles for article (PubMed ID: 25964520)
1. Recent developments in radiosensitization.
Linam J; Yang LX
Anticancer Res; 2015 May; 35(5):2479-85. PubMed ID: 25964520
[TBL] [Abstract][Full Text] [Related]
2. Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.
De Ridder M; Van Esch G; Engels B; Verovski V; Storme G
Bull Cancer; 2008 Mar; 95(3):282-91. PubMed ID: 18390408
[TBL] [Abstract][Full Text] [Related]
3. Radiation sensitization with redox modulators: a promising approach.
Rosenberg A; Knox S
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):343-54. PubMed ID: 16414370
[TBL] [Abstract][Full Text] [Related]
4. Chemical radiosensitizers for use in radiotherapy.
Wardman P
Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):397-417. PubMed ID: 17478086
[TBL] [Abstract][Full Text] [Related]
5. Modulating the radiation response.
Coleman CN
Stem Cells; 1996 Jan; 14(1):10-5. PubMed ID: 8820945
[TBL] [Abstract][Full Text] [Related]
6. [Radiosensitization research in cancer therapy].
Sugahara T
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):405-11. PubMed ID: 3890755
[TBL] [Abstract][Full Text] [Related]
7. Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A review.
Horsman MR
Acta Oncol; 1995; 34(5):571-87. PubMed ID: 7546822
[TBL] [Abstract][Full Text] [Related]
8. Radiosensitization and cell kinetics: clinical implications for S-phase-specific radiosensitizers.
Kinsella TJ
Semin Oncol; 1992 Jun; 19(3 Suppl 9):41-7. PubMed ID: 1641656
[TBL] [Abstract][Full Text] [Related]
9. Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization.
Farhood B; Goradel NH; Mortezaee K; Khanlarkhani N; Salehi E; Nashtaei MS; Mirtavoos-Mahyari H; Motevaseli E; Shabeeb D; Musa AE; Najafi M
Clin Transl Oncol; 2019 Mar; 21(3):268-279. PubMed ID: 30136132
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of radiotherapy with DNA topoisomerase I-targeted drugs.
Chen AY; Chou R; Shih SJ; Lau D; Gandara D
Crit Rev Oncol Hematol; 2004 May; 50(2):111-9. PubMed ID: 15157660
[TBL] [Abstract][Full Text] [Related]
11. Metformin: A Novel Biological Modifier of Tumor Response to Radiation Therapy.
Koritzinsky M
Int J Radiat Oncol Biol Phys; 2015 Oct; 93(2):454-64. PubMed ID: 26383681
[TBL] [Abstract][Full Text] [Related]
12. 5-aminoimidazole-4-carboxamide riboside enhances effect of ionizing radiation in PC3 prostate cancer cells.
Isebaert SF; Swinnen JV; McBride WH; Begg AC; Haustermans KM
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1515-23. PubMed ID: 21944462
[TBL] [Abstract][Full Text] [Related]
13. [Biomodulation and radiotherapy].
Bourhis J; Lartigau E
Cancer Radiother; 2000 Nov; 4 Suppl 1():128s-133s. PubMed ID: 11194950
[TBL] [Abstract][Full Text] [Related]
14. Molecular targets for altering radiosensitivity: lessons from Ras as a pre-clinical and clinical model.
Cengel KA; McKenna WG
Crit Rev Oncol Hematol; 2005 Aug; 55(2):103-16. PubMed ID: 16006139
[TBL] [Abstract][Full Text] [Related]
15. Emerging targets for radioprotection and radiosensitization in radiotherapy.
Kumar S; Singh RK; Meena R
Tumour Biol; 2016 Sep; 37(9):11589-11609. PubMed ID: 27318945
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylation as a target for radiosensitization.
Cerna D; Camphausen K; Tofilon PJ
Curr Top Dev Biol; 2006; 73():173-204. PubMed ID: 16782459
[TBL] [Abstract][Full Text] [Related]
17. [Recent data on biological and clinical properties of radiosensitizers (author's transl)].
Guichard M; Malaise EP
Sem Hop; 1980 Jun 8-15; 56(21-24):1094-107. PubMed ID: 6156491
[TBL] [Abstract][Full Text] [Related]
18. Hypoxic radiosensitizers and hypoxic cytotoxins in radiation oncology.
Weinmann M; Welz S; Bamberg M
Curr Med Chem Anticancer Agents; 2003 Sep; 3(5):364-74. PubMed ID: 12871083
[TBL] [Abstract][Full Text] [Related]
19. Natural Radiosensitizers in Radiotherapy: Cancer Treatment by Combining Ionizing Radiation with Resveratrol.
Komorowska D; Radzik T; Kalenik S; Rodacka A
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142554
[TBL] [Abstract][Full Text] [Related]
20. Selenadiazole derivatives as potent thioredoxin reductase inhibitors that enhance the radiosensitivity of cancer cells.
Liang YW; Zheng J; Li X; Zheng W; Chen T
Eur J Med Chem; 2014 Sep; 84():335-42. PubMed ID: 25036792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]